Sarepta Therapeutics, Inc. (BVMF:S1RP34)

Sarepta Therapeutics Statistics

Total Valuation

BVMF:S1RP34 has a market cap or net worth of BRL 12.67 billion. The enterprise value is 14.84 billion.

Market Cap	12.67B
Enterprise Value	14.84B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.62%
Shares Change (QoQ)	-5.99%
Owned by Insiders (%)	4.70%
Owned by Institutions (%)	85.35%
Float	99.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.27
PS Ratio	0.99
PB Ratio	1.80
P/TBV Ratio	1.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.84, with an EV/FCF ratio of -7.31.

EV / Earnings	-10.26
EV / Sales	1.16
EV / EBITDA	29.84
EV / EBIT	n/a
EV / FCF	-7.31

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.95.

Current Ratio	2.95
Quick Ratio	1.51
Debt / Equity	0.95
Debt / EBITDA	13.43
Debt / FCF	-3.31
Interest Coverage	-3.95

Financial Efficiency

Return on equity (ROE) is -21.37% and return on invested capital (ROIC) is -2.06%.

Return on Equity (ROE)	-21.37%
Return on Assets (ROA)	-1.52%
Return on Invested Capital (ROIC)	-2.06%
Return on Capital Employed (ROCE)	-3.34%
Revenue Per Employee	9.38M
Profits Per Employee	-1.05M
Employee Count	1,372
Asset Turnover	0.68
Inventory Turnover	2.40

Taxes

In the past 12 months, BVMF:S1RP34 has paid 103.01 million in taxes.

Income Tax	103.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.75% in the last 52 weeks. The beta is 0.52, so BVMF:S1RP34's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-85.75%
50-Day Moving Average	5.51
200-Day Moving Average	11.64
Relative Strength Index (RSI)	56.88
Average Volume (20 Days)	8,801

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.22

Income Statement

In the last 12 months, BVMF:S1RP34 had revenue of BRL 12.86 billion and -1.45 billion in losses. Loss per share was -14.77.

Revenue	12.86B
Gross Profit	2.37B
Operating Income	-458.37M
Pretax Income	-1.34B
Net Income	-1.45B
EBITDA	-193.37M
EBIT	-458.37M
Loss Per Share	-14.77

Balance Sheet

The company has 4.54 billion in cash and 6.72 billion in debt, giving a net cash position of -2.18 billion.

Cash & Cash Equivalents	4.54B
Total Debt	6.72B
Net Cash	-2.18B
Net Cash Per Share	n/a
Equity (Book Value)	7.04B
Book Value Per Share	67.15
Working Capital	9.60B

Cash Flow

In the last 12 months, operating cash flow was -1.30 billion and capital expenditures -727.27 million, giving a free cash flow of -2.03 billion.

Operating Cash Flow	-1.30B
Capital Expenditures	-727.27M
Free Cash Flow	-2.03B
FCF Per Share	n/a

Margins

Gross margin is 18.39%, with operating and profit margins of -3.56% and -11.25%.

Gross Margin	18.39%
Operating Margin	-3.56%
Pretax Margin	-10.45%
Profit Margin	-11.25%
EBITDA Margin	-1.50%
EBIT Margin	-3.56%
FCF Margin	n/a

Dividends & Yields

BVMF:S1RP34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.62%
Shareholder Yield	2.62%
Earnings Yield	-11.42%
FCF Yield	-16.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:S1RP34 has an Altman Z-Score of 1.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	3